BIOCRYST PHARMACEUTICALS, INC. Interest Payable, Current
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Interest Payable, Current of $25.55 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2022-02-28
- 2021-09-30: Interest Payable, Current $25.55M.
- 2021-06-30: Interest Payable, Current $25.22M.
- 2021-03-31: Interest Payable, Current $23.55M.
- 2020-12-31: Interest Payable, Current $21.67M.
| Period end | Interest Payable, Current |
|---|---|
| 2021-09-30 | $25.55M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $25.22M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $23.55M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $21.67M 10-K · filed 2022-02-28 |
| 2020-09-30 | $19.30M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $17.81M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $16.38M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $14.90M 10-K · filed 2021-03-01 |
| 2019-09-30 | $13.42M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $14.74M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $13.39M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $11.85M 10-K · filed 2020-03-13 |
| 2018-09-30 | $10.43M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $14.83M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $13.46M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $12.10M 10-K · filed 2019-03-14 |
| 2017-09-30 | $10.71M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $11.59M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $10.29M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $8.99M 10-K · filed 2018-03-12 |
| 2016-09-30 | $7.56M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $9.20M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $7.97M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $6.75M 10-K · filed 2017-02-27 |
| 2015-09-30 | $5.52M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $4.45M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $7.24M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $6.03M 10-K · filed 2016-02-26 |
| 2014-09-30 | $4.82M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $3.79M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $4.55M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $3.87M 10-K · filed 2015-03-02 |
| 2013-09-30 | $2.73M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $3.66M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $3.07M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.00M 10-K · filed 2014-03-10 |
| 2012-09-30 | $928.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $3.50M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $2.45M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $1.40M 10-K · filed 2013-03-11 |
| 2011-09-30 | $350.00K 10-Q · filed 2011-11-03 |
| 2011-09-01 | $4.20M 10-K · filed 2013-03-11 |
| 2011-06-30 | $1.32M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |